Serological investigation of HIV-1 variant subtype strains in transmission in Nairobi

East African Medical Journal

Volumn 73, Issue 2, 1996, Pages 88-90

  Songok, E M ^a   Tukei, P M ^b   Mulaa, F J ^a  

^a UNIVERSITY OF NAIROBI   (Kenya)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; AFRICA SOUTH OF THE SAHARA; AMINO ACID SEQUENCE; ARTICLE; BIOLOGY; CLASSIFICATION; CYTOLOGY; DEVELOPING COUNTRY; DISEASE TRANSMISSION; DISEASES; EASTERN AFRICA; ENGLISH SPEAKING AFRICA; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGY; GENETICS; HEALTH; HEALTH SURVEY; HIV INFECTIONS--TRANSMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; KENYA; MASS SCREENING; MOLECULAR GENETICS; PHYSICAL DISEASE BY BODY FUNCTION; RESEARCH REPORT; SEROTYPING; VIRAL DISEASES; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AFRICA; AFRICA SOUTH OF THE SAHARA; BIOLOGY; CYTOLOGY; DEVELOPING COUNTRIES; DISEASES; EASTERN AFRICA; ENGLISH SPEAKING AFRICA; GENETICS; HIV INFECTIONS--TRANSMISSION; KENYA; RESEARCH REPORT; SIGNS AND SYMPTOMS; VIRAL DISEASES;

AMINO ACID SEQUENCE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIV SEROPOSITIVITY; HIV SEROPREVALENCE; HIV-1; HUMANS; KENYA; MASS SCREENING; MOLECULAR SEQUENCE DATA; POPULATION SURVEILLANCE; SEROEPIDEMIOLOGIC STUDIES; SEROTYPING; URBAN HEALTH;

EID: 0030076798     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Javeherian, K., Langlois, A.J. and McDanal, C. et al Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. Prop. Natl. Acad Sci. USA. 1989; 86:6768-6772.
2. Profy, A.T., Salinas, P.A. and Eckler, L.I et al. Epitopes recognized by neutralizing antibodies of an HIV-1 infected individual. J. Immunol. 1990; 144:4641-4647.
3. Goudsmit, J., Debouck, C. and Meloen, R.H. et al; Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type specific antibodies in experimentally infected chimpanzees. Proc. Natl. Acad. Sci. USA. 1988; 85:4478-4482.
4. Meloen, R.H., Liskamp, R.M. and Goudsmit, J. Specificity and function of the individual and no acids of an important determinant of HIV1 that induces neutralizing activity. J. gen. Virol. 1989; 70:15051512.
5. Puttney, S.D., Matthews, T.J. and Bolognesi, D. et al. HTLVIII/ LAV neutralizing antibodies to an E. coli fragments of the virus envelope. Science. 1986; 234:1392-5.
6. Rusche, J.R., Javeherian, K. and McDaniel,C. et al. Antibodies (hat inhibit fusion of human immunodeficiency virus infected cells bind a 24 amino acid sequence of viral envelope gp120. Proc. Natl. Acad. Sci. USA. 1988; 85:3198-202.
7. Palker, T.J., Clarke, M.E. and Langlois, A.J. et al. Type specific neutralization of human immunodeficiency virus with antibodies of env encoded synthetic peptides. Proc. Natl. Acad. Sci. USA 1988; 85:1-5
8. Devash, Y., Mathews, T.J. and Drummond, J.E. et al. C-terminal fragments og gpl20 and synthetic peptides from five HTLVIII strains:prevalence of antibodies to HTLVIII/MN isolate in infected individuals. AIDS Res. Hum. Retrovir. 1990; 6:307-16
9. Zwart, G., Langeduk, H., and Van de Hoek, L. et al. Immunodominance and antigenic variation of the principal neutralizing domain of HIV-1. Virol. 1991; 181:481-9.
10. Chengsong-popov, R., Callow, D. and Beddows, S. et al: Geographic diversity of human immunodeficiency virus type 1: Serologic reactivity to env epitopes and relationship to neutralization. J. infect. Dis. 1992; 165:256-61.
11. Smith, J.D., Bruce, C.B. and Featherstone, A.S. et al. Reactions of Ugandan antisera with peptides encoded by V3 loop epitopes of HIV-type 1. AIDS Res. Hum. Retrovin 1994; 10:577-83.
12. Jansson, M., Wahren, B. and Albert, J. et al: Peptide serology for analysis of inter and intraindividual variation in the HIV-1 V3 domain. AIDS. 1994; 8:413-21.
13. Fiore, J.R., Jansson, M. and Scarlatti, G. et al. Correlation between seroreactivity to HIV-1 V3 loop peptides and male to female transmission. AIDS. 1993; 7:29-31.